Diagnostic Contract Manufacturing Market Size is valued at USD 25.7 Bn in 2023 and is predicted to reach USD 57.9 Bn by the year 2031 at a 10.78% CAGR during the forecast period for 2024-2031.
Diagnostic contract manufacturing is a vital element of the diagnostics supply chain, providing customized solutions that allow diagnostic organizations to allocate more resources towards product innovation and market growth, all the while capitalizing on specialized manufacturing proficiency. In the diagnostics industry, it is common practice to streamline procedures and tap into the expertise of particular manufacturers. There are several benefits of IVD contract manufacturing.
Diagnostic companies can profit from efficient and cost-effective production while focusing on R&D, marketing, and other key skills by outsourcing to specialized manufacturers. Production costs, operational efficiency, and the time it takes to bring new diagnostic equipment to market might all be improved with this strategy. Companies can access global markets through contract manufacturers, who are already established, and save considerably by investing in infrastructure. Furthermore, innovations in in vitro diagnostics are driving the market forward.
However, the market growth is hampered by the technical issues criteria for the safety and health of the diagnostic contract manufacturing market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high diagnostic contract manufacturing because of issues with intellectual property and the complexity of customizing products. Intellectual property protection becomes more difficult when diagnostic contract businesses and contract manufacturers work together because of the sharing of confidential information and technology. A lack of open collaboration could affect IVD companies' desire to engage in outsourcing partnerships because there are worries regarding the safety of data and the possibility of unlawful exploitation of novel diagnostic technologies. The market for in-vitro diagnostics has been affected in different ways by the COVID-19 epidemic. Even though the pandemic immediately hampered research and laboratory operations, it ultimately brought attention to the need for RNA-based research and therapies.
The diagnostic contract manufacturing market is segmented based on device, service and application. The Device segment comprises In Vitro Diagnostic Devices (IVD Consumables, IVD Equipment), Diagnostic Imaging Devices (X-ray, CT scan, Ultrasound, MRI, Others), and Other Devices. Whereas, By Service, the market is segmented as Device Development & Manufacturing, Quality Management, and Packaging & Assembly. The Application segment includes In Vitro Diagnostic Devices (Infectious Diseases, Diabetes, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Neurology, Orthopedics, Oncology, Others), and Other Devices (Gastroenterology, Gynecology, Others).
The in vitro diagnostic devices diagnostic contract manufacturing market is expected to lead with a major global market share in 2023. In vitro diagnostic procedures involve the examination of a patient's blood or tissue samples. They help monitor the patient's vitals and are utilized for precise diagnostic testing of illnesses and other underlying conditions. Each patient's best course of treatment can be better determined with the help of these diagnostic tests. With the rise in both acute and chronic disorders continuing to rise, the in vitro diagnostics business is seeing rapid growth.
The quality management industry uses the bulk of acrylic acid ester usage because, with the support of a quality management system (QMS), customers may be confident that their needs will be fully addressed, if not surpassed. In order to optimize operations, reduce waste, and identify and eliminate process inefficiencies, a corporation should develop a quality management system, especially in countries like the US, Germany, the UK, China, and India.
The Asia Pacific diagnostic contract manufacturing market is expected to register the large market share in revenue in the near future. It can be attributed to increasing supportive government policies and a robust diagnostic system. In addition, North America is projected to grow rapidly in the global diagnostic contract manufacturing market because of the improvement of healthcare facilities and the increasing presence of many target groups in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 25.7 Bn |
|
Revenue Forecast In 2031 |
USD 57.9 Bn |
|
Growth Rate CAGR |
CAGR of 10.78% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Device, Services, And Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Jabil Inc., Flex Ltd., Plexus Corp, Sanmina Corporation, TE Connectivity Ltd., Celestica Inc., Integer Holdings Corporation, Nipro Medical Corporation, Thermo Fisher Scientific, West Pharmaceutical Services, Inc., Benchmark Electronics Inc., Kimball Electronics Inc., KMC Systems Savyon Diagnostics, Nova Biomedical, Cenogenic Corporation, Cone Bioproducts, Avioq Inc., Philips-Medisize Corporation, Invetech, Meridian Bioscience, Inc., Nolato AB, Fujirebio, Sekisui Prestige Diagnostics, Biokit, Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Diagnostic Contract Manufacturing Market Snapshot
Chapter 4. Global Diagnostic Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis
5.1. by Product & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product:
5.2.1. In Vitro Diagnostic Devices
5.2.1.1. IVD Consumables
5.2.1.2. IVD Equipment
5.2.2. Diagnostic Imaging Devices
5.2.2.1. CT
5.2.2.2. X-ray
5.2.2.3. Ultrasound
5.2.2.4. MRI
5.2.2.5. Others
5.2.3. Other Devices
Chapter 6. Market Segmentation 2: by Service Estimates & Trend Analysis
6.1. by Service & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Service:
6.2.1. Device Development and Manufacturing Services
6.2.2. Quality Management Services
6.2.3. Packaging and Assembly Services
6.2.4. Other Services
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. In Vitro Diagnostic Devices
7.2.1.1. Infectious Diseases
7.2.1.2. Diabetes
7.2.1.3. Oncology
7.2.1.4. Cardiology
7.2.1.5. Other Applications
7.2.2. Diagnostic Imaging Device
7.2.2.1. Cardiology
7.2.2.2. Oncology
7.2.2.3. Orthopedics
7.2.2.4. Neurology
7.2.2.5. Other Applications
7.2.3. Other Devices
7.2.3.1. Gastroenterology
7.2.3.2. Gynecology
7.2.3.3. Other Application
Chapter 8. Diagnostic Contract Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.1.2. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031
8.1.3. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.1.4. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.2.2. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031
8.2.3. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.4. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.3.2. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031
8.3.3. Asia-Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.4. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.4.2. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031
8.4.3. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.4.4. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.5.2. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031
8.5.3. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.4. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Jabil Inc.
9.2.2. Flex Ltd.
9.2.3. Plexus Corp
9.2.4. Sanmina Corporation
9.2.5. TE Connectivity Ltd.
9.2.6. Celestica Inc.
9.2.7. Integer Holdings Corporation
9.2.8. Nipro Medical Corporation
9.2.9. Thermo Fisher Scientific
9.2.10. West Pharmaceutical Services, Inc.
9.2.11. Benchmark Electronics Inc.
9.2.12. Kimball Electronics Inc.
9.2.13. KMC Systems
9.2.14. Savyon Diagnostics
9.2.15. Nova Biomedical
9.2.16. Cenogenic Corporation
9.2.17. Cone Bioproducts
9.2.18. Avioq Inc.
9.2.19. Philips-Medisize Corporation
9.2.20. Invetech
9.2.21. Meridian Bioscience, Inc.
9.2.22. Nolato AB
9.2.23. Fujirebio
9.2.24. Sekisui
9.2.25. Prestige Diagnostics
9.2.26. Biokit
9.2.27. Other Market Players
Diagnostic Contract Manufacturing Market By Device-
Diagnostic Contract Manufacturing Market By Service-
Diagnostic Contract Manufacturing Market By Application-
Diagnostic Contract Manufacturing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
